MedTech Europe have set deadline for feedback at 19th September, therefore BIVDA members would need to inform us by the 18th September. Note also the comment from the previous week's update that one of the substances is flagged as having medical or healthcare applications already identified. Octamethyltrisiloxane (EC 203-497-4, CAS 107-51-7) à the proposal lists medical and healthcare applications among…
Ben KempSeptember 11, 2024